| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 11 May 2026 | 30 Apr 2026 |
| Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve Audited Financial Results of the Company for the quarter and financial year ended March 31, 2026, along with the Audit Report of the Statutory Auditors thereon and to recommend final dividend for the financial year ended March 31, 2026. Outcome of Board Meeting (As per BSE Announcement dated on: 11.05.2026) | ||
| Board Meeting | 22 Apr 2026 | 22 Apr 2026 |
| Outcome of Board Meeting. Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. | ||
| Board Meeting | 12 Feb 2026 | 4 Feb 2026 |
| Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2025. Outcome of Board Meeting. (As per BSE announcement dated on : 12.02.2026) | ||
| Board Meeting | 6 Nov 2025 | 29 Oct 2025 |
| Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2025. Outcome of Board Meeting. (As per BSE Announcement dated on: 06.11.2025) | ||
| Board Meeting | 12 Aug 2025 | 4 Aug 2025 |
| Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Unaudited Financial Results for the quarter ended on June 30 2025. Outcome of Board Meeting. (As Per BSE Announcement Dated on: 12/08/2025) | ||
Sitagliptin has played a crucial role in managing type 2 diabetes by lowering HbA1c levels and improving blood sugar control.
Here are some of the stocks that may see significant price movement today: Jio Financial Service, Hero MotoCorp, Abbott India, etc.
The Board of Directors has recommended Final Dividend of ₹ 475 per equity share (of Face Value ₹10/- each) for the year ended March 31, 2025.
Here are some of the stocks that may see significant price movement today: JSW Energy, Abbott India, Patanjali Foods, etc.
EBITDA increased by 10.2% to ₹391.1 Crore in the first quarter of this fiscal year, up from ₹355 Crore the previous year.
Here are some of the stocks that may see significant price movement today: Godrej Consumer Products, Hindalco Industries, Abbott India, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
